ROS, E. O. The US FDA-Approved Drug Dimethyl Fumarate, an Nrf2 Activator, for Treating Multiple Sclerosis: The Mechanisms of Action Revisited. Reactive Oxygen Species, [S. l.], v. 11, p. n7–n8, 2021. DOI: 10.20455/ros.2021.n.807. Disponível em: https://rosj.org/index.php/ros/article/view/286. Acesso em: 14 apr. 2021.